Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Pembrolizumab + Radiation Therapy for Non-Hodgkin's Lymphoma
Recruiting2 awardsPhase 2
Houston, Texas
This trial is testing pembrolizumab with radiation therapy to see if it is more effective than pembrolizumab alone in treating patients with non-Hodgkin lymphoma that has returned or does not respond to treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.